FATE THERAPEUTICS INC (FATE) is a publicly traded company in the Unknown sector. Across all available filings, 32 corporate insiders have executed 617 transactions totaling $291.7M, demonstrating a bullish sentiment with $33.5M in net insider flow. The most recent transaction on Jan 9, 2026 involved a sale of 5,190 shares valued at $5.6K.
No significant insider buying has been recorded for FATE in the recent period.
No significant insider selling has been recorded for FATE in the recent period.
Based on recent SEC filings, insider sentiment for FATE is bullish with an Insider Alignment Score of 56/100 and a net flow of $33.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at FATE THERAPEUTICS INC (FATE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 32 insiders are actively trading FATE stock, having executed 617 transactions in the past 90 days. The most active insider is Jeremy Green (Executive), who has made 9 transactions totaling $132.8M.
Get notified when executives and directors at FATE file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 9, 2026 | Valamehr Bahram | Executive | Sale | 5,190 | $1.07 | $5.6K | |
| Jan 9, 2026 | Tahl Cindy | See Remarks | Sale | 10,589 | $1.06 | $11.3K | |
| Oct 20, 2025 | Adawi Kamal | Executive | Award | 75,000 | $N/A | $0 | |
| Aug 4, 2025 | Valamehr Bahram | Executive | Sale | 14,466 | $1.06 | $15.3K | |
| Aug 4, 2025 | Tahl Cindy | Executive | Sale | 9,037 | $1.06 | $9.6K | |
| Aug 6, 2024 | Xu Yuan | Executive | Sale | 633 | $4.23 | $2.7K | 10b5-1 |
| Jul 29, 2024 | Tahl Cindy | Executive | Award | 200,000 | $N/A | $0 | |
| Jul 29, 2024 | Valamehr Bahram | Executive | Award | 200,000 | $N/A | $0 | |
| Mar 4, 2024 | J. Dulac Edward III | Executive | Sale | 2,447 | $7.77 | $19.0K | 10b5-1 |
| Jan 29, 2024 | J. Dulac Edward III | Executive | Sale | 1,849 | $5.00 | $9.2K | 10b5-1 |
| Jan 9, 2024 | J. Dulac Edward III | Executive | Sale | 7,028 | $4.37 | $30.7K | |
| Jan 9, 2024 | Scott Wolchko J. | Executive | Sale | 14,391 | $4.37 | $62.9K | |
| Jan 9, 2024 | Valamehr Bahram | Executive | Sale | 11,271 | $4.38 | $49.4K | |
| Jan 9, 2024 | Tahl Cindy | Executive | Sale | 10,874 | $4.37 | $47.5K | |
| Jan 2, 2024 | J. Dulac Edward III | Executive | Sale | 5,182 | $3.66 | $19.0K | 10b5-1 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 26 | $162.6M | 42.8% |
Sale(S) | 373 | $129.1M | 34.0% |
Other(J) | 17 | $81.0M | 21.4% |
Exercise(M) | 106 | $6.7M | 1.8% |
Award(A) | 64 | $0 | 0.0% |
Conversion(C) | 28 | $0 | 0.0% |
Gift(G) | 3 | $0 | 0.0% |
Insider activity at FATE THERAPEUTICS INC shows mixed signals across all time. While $162.6M in purchases indicates some executive confidence,$129.1M in sales balances the picture, resulting in a modest net flow of $33.5M.32 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Jeremy Green, has transacted $132.8M during this period.